» Articles » PMID: 20634043

Diabetes, Cardiovascular Disease, and Health Care Use in People with and Without Schizophrenia

Overview
Journal Eur Psychiatry
Specialty Psychiatry
Date 2010 Jul 17
PMID 20634043
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: To compare the prevalence of cardiovascular risk factors (CV-RF) and disease (CV-D) and health care use in people with and without schizophrenia. SUBJECTS/MATERIALS AND METHODS: Data from the Canadian Community Health Survey (CCHS), cycle 3.1, were used. Prevalence of CV-RF, CV-D, and health care use were compared in those with and without schizophrenia using logistic regression analysis. Sampling weights and bootstrap variance estimates were used to account for survey design.

Results: A total of 399 (0.3%) people with schizophrenia were identified and compared to 120,044 (97.7%) people without. Individuals with schizophrenia were significantly more likely to be obese (34.8% vs. 15.6%) and report diabetes (11.9% vs. 5.3%). After accounting for sociodemographic variables, schizophrenia was not independently associated with diabetes (adjusted odds ratio [aOR]: 0.86; 0.49-1.51). Individuals with schizophrenia were more likely to be hospitalized (21.9% vs. 8.0%; aOR: 2.37; 95% CI: 1.51-3.74) but no more likely to visit their physician (86.7% vs. 85.7%; aOR: 1.23; 95% CI: 0.65-2.35).

Discussion/conclusion: Our findings suggest that people with schizophrenia access the primary health care system at least as frequently as someone without schizophrenia, and the opportunity for management of modifiable CV-RF exists in this vulnerable population.

Citing Articles

Schizophrenia and type 2 diabetes risk: a systematic review and meta-analysis.

Dong K, Wang S, Qu C, Zheng K, Sun P Front Endocrinol (Lausanne). 2024; 15:1395771.

PMID: 39324122 PMC: 11422011. DOI: 10.3389/fendo.2024.1395771.


Electrocardiogram abnormalities and associated factors among psychiatric patients attending follow up at Jimma Medical Center Psychiatry Clinic, Jimma, Ethiopia: an institution-based cross-sectional study.

Girma B, Wondie A, Debebe W, Juhar A, Tegene E, Bedane D BMC Cardiovasc Disord. 2023; 23(1):178.

PMID: 37005595 PMC: 10066966. DOI: 10.1186/s12872-023-03092-3.


Prevalence, incidence and mortality from cardiovascular disease in patients with pooled and specific severe mental illness: a large-scale meta-analysis of 3,211,768 patients and 113,383,368 controls.

Correll C, Solmi M, Veronese N, Bortolato B, Rosson S, Santonastaso P World Psychiatry. 2017; 16(2):163-180.

PMID: 28498599 PMC: 5428179. DOI: 10.1002/wps.20420.


Resveratrol Supplementation in Schizophrenia Patients: A Randomized Clinical Trial Evaluating Serum Glucose and Cardiovascular Risk Factors.

Zortea K, Franco V, Francesconi L, Cereser K, Lobato M, Belmonte-de-Abreu P Nutrients. 2016; 8(2):73.

PMID: 26840331 PMC: 4772037. DOI: 10.3390/nu8020073.


An evaluation of variation in published estimates of schizophrenia prevalence from 1990─2013: a systematic literature review.

Simeone J, Ward A, Rotella P, Collins J, Windisch R BMC Psychiatry. 2015; 15:193.

PMID: 26263900 PMC: 4533792. DOI: 10.1186/s12888-015-0578-7.